Skip to main content Help with accessibility Skip to main navigation

Empagliflozin

Indication

Chronic heart failure with preserved or mildly reduced ejection fraction (NICE TA929)

NICE TA929 - Empagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction

Amber level 0

Brand:

Nice TA:

929

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Cardiovascular system

Background

1.1 Empagliflozin is recommended, within its marketing authorisation, as an option for treating symptomatic chronic heart failure with preserved or mildly reduced ejection fraction in adults.

Recommendation

LSCMMG Recommendation:

Amber level 0

Reason for decision:

Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

Decisions of Lancashire local decision making groups

BwD
BP
CSR
EL
FW
GP
MB
WL
Amber 0
Amber 0
Amber 0
Amber 0
Amber 0
Amber 0
Amber 0
Amber 0
What do the colours mean?

Last Updated: 13 - Feb - 2024